Phathom Pharmaceuticals, Inc. (PHAT)

11.34 +0.20 (+1.80%) USD  |  NASDAQ  |  Apr 02, 16:00
11.34 0.00 (0.00%) Pre-Market: 20:00
More

Phathom Pharmaceuticals EBIT (% of Annual Revenues)

EBIT (% of Annual Revenues) Chart

View EBIT (% of Annual Revenues) for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (% of Annual Revenues) Range, Past 5 Years

View EBIT (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (% of Annual Revenues) Benchmarks

View EBIT (% of Annual Revenues) Benchmarks
Start Trial
Replimune Group, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Ocugen, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade